Xueying Qiao
Shijiazhuang, 050011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Corrigendum to "Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma". [Europ J Surg Oncol 51 (2025) 109546].
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 07, 2025
Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: October 01, 2024
The impact of radiation-related lymphocyte recovery on the prognosis of locally advanced esophageal squamous cell carcinoma patients: a retrospective analysis.
Journal: Radiation oncology (London, England)
Published: July 10, 2024
Elective nodal irradiation versus involved-field irradiation for stage II-IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes.
Journal: Radiation oncology (London, England)
Published: October 18, 2022
Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis.
Journal: Therapeutic advances in medical oncology
Published: June 09, 2022
Treatment and outcome of a patient with pleural unilocular cystic mesothelial proliferation.
Journal: Respirology case reports
Published: May 06, 2022
Primary Epithelial-Myoepithelial Carcinoma of the Lung Presenting as Multiple Synchronous Lesions.
Journal: The Annals of thoracic surgery
Published: October 21, 2021
Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction.
Journal: Frontiers in oncology
Published: August 10, 2021
The promising outcome with simultaneous integrated boost intensity modulated radiotherapy in confined nasal extranodal NK/T-cell lymphoma.
Journal: Leukemia & lymphoma
Published: July 15, 2021
Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG Survey.
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 01, 2021
Age plays an important role in the decision of definitive concurrent chemoradiotherapy (CCRT) for esophageal squamous cell carcinoma (ESCC): a propensity-score matched analysis of multicenter data (3JECROG R-02A).
Journal: Translational cancer research
Published: February 07, 2021
Last Updated: 09/26/2026